Pharmafile Logo
Pharmafocus logo
Advanced Search

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025
Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …

News
handshake2

Jérôme Berger announced as strategy and finance executive at Vect-Horus

January 28, 2025
appointment, private biotechnology company

Vect-Horus, a private biotechnology company specialising in molecular development, has announced the appointment of Jérôme Berger to its board of …

Appointment

Research collaboration announced between Oxford University and GSK

January 27, 2025
Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

News

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

January 23, 2025
Paris, Pharmapack 2025, Winners, pharmaceutical packaging and drug delivery

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexyâ„¢ reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilockâ„¢ …

News
Press release

Combination first-in-line treatment approved for patients with non-small cell lung cancer

January 23, 2025
Research and Development J&J Innovative Medicine, Oncology, approval, non-small cell lung cancer

Johnson & Johnson Innovative Medicine  have announced that the European Commission (EC) has approved a marketing authorisation for the combination …

News

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

January 23, 2025
Medical Communications, Public Relations Heart of Pharma, Paris, pharmapack

Six start-ups bestowed with new ‘heart of pharma’ commendation in recognition of innovations advancing drug delivery and packaging 22 January …

News
Press release

Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project 

January 22, 2025
Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project

Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …

News

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark

January 21, 2025
Sales and Marketing CSL, Denmark, genetic, haemophilia, treatment

21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B …

News
Press release

Uniphar appoints new global head of Scientific Communications

January 17, 2025
UniPhar, appointment

Global partner to pharma, medtech and biotech companies Uniphar has announced the appointment of industry leader Isaac Batley as its …

Appointment

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

January 17, 2025
CPhI, Pharmpack, biologics, predictions

Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025 13 …

News
Press release

David Loose appointed CEO of Essex Management

January 17, 2025

David Loose has been appointed as chief executive officer of Essex Management, part of contract research organisation Emmes Group. After …

Appointment

Dr Joerg Moeller appointed CEO of Antag Therapeutics

January 14, 2025
Corporate

Novel obesity treatment-focused biopharmaceutical company Antag Therapeutics has announced the appointment of Joerg Moeller MD PhD as chief executive officer. …

Appointment

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

January 14, 2025
Switzerland, pharmapack, report

 Pharmapack Europe: ‘Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and …

News
Press release

University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients

January 14, 2025
Research and Development Endocrinology, Oncology, Sheffield, astranzeneca, bladder cancer, immunotherapy, patients

The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …

News

AnaCardio raises $19m in funding round for heart failure candidate

January 10, 2025
Research and Development AnaCardio, Cardiology, cardiology, funding, heart failure

Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for …

News
handshake_2

IDDI announces two new appointments to its leadership team

January 9, 2025
IDDI, appointment, leadership

The International Drug Development Institute (IDDI) has announced changes to its executive leadership team to strengthen the company’s leadership and …

Appointment

University of Southern Denmark pairs with Argobio to launch next-generation RNA company Inverna Therapeutics

January 7, 2025
Research and Development Argobio, Huntingdon's Disease, Inverna therapeutics, Neurology, RNA therapeutics, University of Southern Denmark ], gene splicing

The launch of new RNA company Inverna Therapeutics was announced today. Inerva Therapeutics begins with a programme aimed at transforming …

News

NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA

January 6, 2025
CMT, FDA, NMD Pharma, Orphan Drugs, Pain, nervous system, research and development

Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease …

News

NDA in China receives priority review status for lung cancer treatment

January 3, 2025
Research and Development China, China National Medical products Administration, HUTCHMED, NDA, Oncology, epidermal growth factor receptor, non-small cell lung cancer, priority review

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug …

News

NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer

December 19, 2024
ESR1, Menari Group, NICE, breast cancer, drug

Elacestrant is the first tailored treatment for certain people with oestrogen receptor (ER)-positive HER2-negative locally advanced and metastatic breast cancer …

News
Press release
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026